MyCartis appoints Philippe Stas as CEO Hilde Windels to join the Board of Directors as Executive Chair
The Belgium based immuno-diagnostic company MyCartis announced today it has strengthened its management team by appointing Philippe Stas as CEO and Hilde Windels as Executive Chair.
Prior to joining MyCartis, Mr. Stas was CEO of Trinean, a life science tools company specialized in quality control of biological samples. Over the past 20 years, Philippe held several management roles at Perkin Elmer, Algonomics, Lonza, and currently serves on the Board of ImmunXperts. Philippe has a solid scientific knowledge in biotechnology and bioinformatics, combined with managerial and business development skills.
Philippe Stas commented: “I am excited to join the Mycartis team at this stage. Our platform offers our partners a unique real-time multiplex immuno-diagnostics technology. We provide fast and highly sensitive assays with a large dynamic range. Currently, Mycartis focusses its product development in the fields of (immuno-)oncology and autoimmune diseases.”
Over the past 6 years, Hilde Windels was respectively CFO and co-CEO at Biocartis, where she still serves as a board member. Mrs. Windels is also Board member of Ablynx, Erytech and VIB.
“In June, Mycartis concluded its 10 million EUR C- round allowing the company to further develop its diagnostic platform Evalution and make it available to partners.” stated Hilde Windels.> Back